These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 22001292)

  • 1. Dysregulated atrial gene expression of osteoprotegerin/receptor activator of nuclear factor-κB (RANK)/RANK ligand axis in the development and progression of atrial fibrillation.
    Cao H; Wang J; Xi L; Røe OD; Chen Y; Wang D
    Circ J; 2011; 75(12):2781-8. PubMed ID: 22001292
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Osteoprotegerin/RANK/RANKL axis and atrial remodeling in mitral valvular patients with atrial fibrillation.
    Cao H; Li Q; Li M; Od R; Wu Z; Zhou Q; Cao B; Chen B; Chen Y; Wang D
    Int J Cardiol; 2013 Jul; 166(3):702-8. PubMed ID: 22178057
    [TBL] [Abstract][Full Text] [Related]  

  • 3. OPG/RANK/RANKL axis in stabilization of spontaneously restored sinus rhythm in permanent atrial fibrillation patients after mitral valve surgery.
    Xi L; Cao H; Zhu J; Røe OD; Li M; Wu Y; Wang D; Chen Y
    Cardiology; 2013; 124(1):18-24. PubMed ID: 23295350
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Osteoprotegerin/RANK/RANKL axis in cardiac remodeling due to immuno-inflammatory myocardial disease.
    Liu W; Feng W; Wang F; Li W; Gao C; Zhou B; Ma M
    Exp Mol Pathol; 2008 Jun; 84(3):213-7. PubMed ID: 18417124
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Changes in gelatinases expression and activity in human atria during atrial fibrillation].
    Ke D; Xu CX; Zhang JC; Chen L; Lin YZ; Lin LF; Hu XZ
    Zhonghua Xin Xue Guan Bing Za Zhi; 2005 Feb; 33(2):137-42. PubMed ID: 15924808
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum levels of the osteoprotegerin, receptor activator of nuclear factor kappa-B ligand, metalloproteinase-1 (MMP-1) and tissue inhibitors of MMP-1 levels are increased in men 6 months after acute myocardial infarction.
    Halapas A; Zacharoulis A; Theocharis S; Karavidas A; Korres D; Papadopoulos K; Katopodis H; Stavropoulou A; Lembessis P; Xiromeritis C; Zacharoulis A; Koutsilieris M
    Clin Chem Lab Med; 2008; 46(4):510-6. PubMed ID: 18298349
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preoperative serum receptor activator of nuclear factor-κB ligand/osteoprotegerin predict stabilization of spontaneously restored sinus rhythm in persistent atrial fibrillation patients after mitral valve surgery.
    Cao H; Zhu J; Xi L; Røe OD; Chen Y; Wang D
    Cardiology; 2014; 127(3):183-9. PubMed ID: 24434592
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effects of matrix metalloproteinase-9 and tissue inhibitor-1 of metalloproteinase expression on atrial structural remodeling during chronic atrial fibrillation].
    Zhu H; Zhang W; Guo CH; Zhang G; Zhang WD; Zhong M; Yang GR; Ge ZM; Zhang Y
    Zhonghua Yi Xue Za Zhi; 2005 Jan; 85(1):45-8. PubMed ID: 15808077
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dysregulated osteoprotegerin/RANK ligand/RANK axis in clinical and experimental heart failure.
    Ueland T; Yndestad A; Øie E; Florholmen G; Halvorsen B; Frøland SS; Simonsen S; Christensen G; Gullestad L; Aukrust P
    Circulation; 2005 May; 111(19):2461-8. PubMed ID: 15883214
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interrelationship of circulating matrix metalloproteinase-9, TNF-α, and OPG/RANK/RANKL systems in COPD patients with osteoporosis.
    Zhang PF; Pan L; Luo ZY; Zhao HJ; Cai SX
    COPD; 2013 Dec; 10(6):650-6. PubMed ID: 23845033
    [TBL] [Abstract][Full Text] [Related]  

  • 11. OPG/RANK/RANKL axis as a potential therapeutic target for atrial fibrillation.
    Tao H; Shi K; Yang JJ
    Cardiology; 2013; 125(3):173. PubMed ID: 23751957
    [No Abstract]   [Full Text] [Related]  

  • 12. Expression of the RANK/RANKL/OPG system in the human intervertebral disc: implication for the pathogenesis of intervertebral disc degeneration.
    Sano T; Akeda K; Yamada J; Takegami N; Sudo T; Sudo A
    BMC Musculoskelet Disord; 2019 May; 20(1):225. PubMed ID: 31101043
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of osteoprotegerin, RNAK and RANKL genes in femoral head avascular necrosis and related signaling pathway.
    Miao Q; Hao S; Li H; Sun F; Wang X
    Int J Clin Exp Pathol; 2015; 8(9):10460-7. PubMed ID: 26617755
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Matrix metalloproteinases and atrial remodeling in patients with mitral valve disease and atrial fibrillation.
    Anné W; Willems R; Roskams T; Sergeant P; Herijgers P; Holemans P; Ector H; Heidbüchel H
    Cardiovasc Res; 2005 Sep; 67(4):655-66. PubMed ID: 15913581
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preoperative serum soluble receptor activator of nuclear factor-κB ligand and osteoprotegerin predict postoperative atrial fibrillation in patients undergoing cardiac valve surgery.
    Cao H; Zhou Q; Wu Y; Li Q; Røe OD; Chen Y; Wu Z; Wang D
    Ann Thorac Surg; 2013 Sep; 96(3):800-6. PubMed ID: 23870696
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RANK/RANKL/OPG system in the intervertebral disc.
    Takegami N; Akeda K; Yamada J; Sano T; Murata K; Huang J; Masuda K; Sudo A
    Arthritis Res Ther; 2017 Jun; 19(1):121. PubMed ID: 28576140
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The osteoprotegerin/receptor activator of nuclear factor kappaB/receptor activator of nuclear factor kappaB ligand system in cartilage.
    Komuro H; Olee T; Kühn K; Quach J; Brinson DC; Shikhman A; Valbracht J; Creighton-Achermann L; Lotz M
    Arthritis Rheum; 2001 Dec; 44(12):2768-76. PubMed ID: 11762937
    [TBL] [Abstract][Full Text] [Related]  

  • 18. OPG/RANK/RANKL axis in atrial fibrillation.
    Xi L; Cao H; Chen Y
    Cardiology; 2013; 125(3):174-5. PubMed ID: 23752030
    [No Abstract]   [Full Text] [Related]  

  • 19. Upregulation of matrix metalloproteinase-9 and tissue inhibitors of metalloproteinases in rapid atrial pacing-induced atrial fibrillation.
    Chen CL; Huang SK; Lin JL; Lai LP; Lai SC; Liu CW; Chen WC; Wen CH; Lin CS
    J Mol Cell Cardiol; 2008 Dec; 45(6):742-53. PubMed ID: 18692064
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Relationship between Serum and Gene Expression Levels of RANK, RANKL and Osteoprotegerin Inflammatory Pathway with Unstable Angina: A Case-control Study.
    Farrokhian A; Miraftab M; Chenari M; Akbari H; Nikoueinejad H; Naimi E
    Iran J Allergy Asthma Immunol; 2021 Aug; 20(4):473-483. PubMed ID: 34418901
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.